A securities class action has been filed in the USDC – S.D.N.Y. against Perrigo Company plc (PRGO) (“Perrigo” or the “Company”), on behalf of all persons and entities that purchased or otherwise acquired Perrigo securities between February 27, 2023, and November 4, 2025, both dates inclusive (the “Class Period”).
Perrigo provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The Company manufactures and markets various home health products, including infant formula, toothbrushes, and pain relievers. Perrigo reports sales by geography and product category. For example, the “Nutrition” category primarily represents sales of infant formula. The Nutrition category is also the Company’s third largest by sales in North America, representing approximately 17% of the Company’s fiscal year 2024 sales in that segment.
The Complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors:
(1) that the infant formula business acquired from Nestlé suffered from significant underinvestment in maintenance, operational improvements, and repairs;
(2) that Perrigo needed to make substantial capital and operational expenditures above the Company’s outwardly stated cost estimates to remediate the infant formula business;
(3) that there were significant manufacturing deficiencies in the facility for the Company’s infant formula business;
(4) that, as a result of the foregoing, the Company’s financial results, including earnings and cash flow, were overstated; and
(5) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis, thereby harming investors.
Perrigo’s stock price fell $5.09, or 25.2%, to close at $15.10 per share on November 5, 2025.
If you purchased Perrigo securities during the Class Period and would like to receive more information or join the action, please enter your contact information below for a FREE consultation and click “Submit Your Information”.